2012
DOI: 10.1016/j.humimm.2012.04.005
|View full text |Cite
|
Sign up to set email alerts
|

Genetic variants in the chemokines and chemokine receptors in Chagas disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
53
3

Year Published

2012
2012
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(60 citation statements)
references
References 46 publications
4
53
3
Order By: Relevance
“…The findings are in line with previous associations of chemokine or chemokine receptor polymorphisms in CCC (CCL2 [57], CCL5 [58], CCR5 [29], [58]. However, to our knowledge, is the first study to find gene polymorphisms associated to the transition to CCC with ventricular dysfunction, which is the most clinically relevant presentation of disease, the one associated with significant morbidity and mortality.…”
Section: Discussionsupporting
confidence: 91%
“…The findings are in line with previous associations of chemokine or chemokine receptor polymorphisms in CCC (CCL2 [57], CCL5 [58], CCR5 [29], [58]. However, to our knowledge, is the first study to find gene polymorphisms associated to the transition to CCC with ventricular dysfunction, which is the most clinically relevant presentation of disease, the one associated with significant morbidity and mortality.…”
Section: Discussionsupporting
confidence: 91%
“…Although these SNPs were not studied before, is in line with the literature in studies performed in other Latin American countries with diverse ethnic compositions, where several SNPs were located in the 5′UTR of the CCR5 gene where they may influence binding of regulatory elements to gene expression control regions [22,47,48,61]. As suggested by Florez et al , these polymorphisms do not act independently [61]. Multiple polymorphic changes in the promoter may influence in a differential way the levels of CCR5 expression and the type of cell in which it is expressed.…”
Section: Resultssupporting
confidence: 69%
“…In humans, infection is characterized by 2 phases: an acute phase, which is generally asymptomatic, and a chronic phase, asymptomatic (indeterminate) or symptomatic T. cruzi genetic variability is increasingly recognized and this parasite has been genetically classified into six discrete typing units (DTUs) -TcI to TcVI (Zingales et al, 2009), -which have different geographic distributions and may be associated with geographically-restricted clinical profiles (Tibayrenc and Telleria, 2010). Several data indicate that human genetic determinants may impact the clinical outcome of Chagas disease (Florez et al, 2012;Vasconcelos et al, 2012). However, a role for genetic variability among the different parasite strains in the diverse clinical outcomes of Chagas disease cannot be excluded.…”
Section: Chagas Disease Is a Neglected Tropical Disease Caused By Thementioning
confidence: 99%